Latest News

GeoVax to Present at the 2018 ASM Microbe Conference
GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” Vaccine Industry Excellence Award...
Continue Reading...
GeoVax Awarded NIH Grant for Novel Zika Vaccine
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today ...
Continue Reading...
GeoVax to Conduct Partnering Meetings During BIO International Convention June 4-7
CEO Robert McNally to Speak as part of BIO’s One Health Day Program GeoVax Labs, Inc. (OTCQB: GOVX)...
Continue Reading...